ReviewCureus2023

An Investigation on the Efficacy of Glucagon-Like Peptide 1 Receptor Agonists Drugs in Reducing Urine Albumin-to-Creatinine Ratio in Patients With Type 2 Diabetes: A Potential Treatment for Diabetic Nephropathy.

Chetan Yarlagadda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.